MED Medifast Inc
- Stocks
- Consumer Cyclical
- NYSE: MED
Price (delayed)
$11.8
Market cap
$129.7M
P/E Ratio
590
Dividend/share
N/A
EPS
$0.02
Enterprise value
$42.43M
Relative Growth:
Rel. Growth:
0
Relative Strength:
Rel. Strength:
23
Relative Valuation:
Rel. Valuation:
65
Relative Profitability:
Rel. Profitability:
34
Medifast is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers scientifically developed products, clinically proven plans and the support of Coaches and a
Highlights
The company's quick ratio has surged by 58% YoY and by 5% QoQ
Medifast's debt has decreased by 30% YoY and by 6% from the previous quarter
MED's net income has shrunk by 97% YoY and by 93% QoQ
The EPS has dropped by 97% year-on-year and by 94% since the previous quarter
Key stats
What are the main financial stats of MED
Market
Valuations
Earnings
Shares outstanding
10.99M
Market cap
$129.7M
Enterprise value
$42.43M
Price to earnings (P/E)
590
Price to book (P/B)
0.6
Price to sales (P/S)
0.3
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
2.69
EV/Sales
0.1
Revenue
$429.7M
Gross profit
$311.27M
Operating income
-$5.7M
Net income
$248,000
EBIT
-$2.79M
EBITDA
$15.77M
Free cash flow
$646,000
Per share
Balance sheet
Liquidity
EPS
$0.02
EPS diluted
$0.01
Free cash flow per share
$0.06
Book value per share
$19.53
Revenue per share
$39.1
TBVPS
$24.4
Total assets
$268.21M
Total liabilities
$53.5M
Debt
$12.26M
Equity
$214.71M
Working capital
$161.13M
Debt to equity
0.06
Current ratio
4.45
Quick ratio
3.71
Net debt/EBITDA
-5.53
Margins
Efficiency
Dividend
EBITDA margin
3.7%
Gross margin
72.4%
Net margin
0.1%
Operating margin
-1.3%
Return on assets
0.1%
Return on equity
0.1%
Return on invested capital
-2%
Return on capital employed
-1.3%
Return on sales
-0.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MED stock price
How has the Medifast stock price performed over time
Intraday
-3.12%
1 week
-2.8%
1 month
-15.41%
1 year
-40.1%
YTD
-33.03%
QTD
-13.68%
Financial performance
How have Medifast's revenue and profit performed over time
Revenue
$429.7M
Gross profit
$311.27M
Operating income
-$5.7M
Net income
$248,000
Gross margin
72.4%
Net margin
0.1%
Medifast's operating margin has shrunk by 181% YoY
The operating income has shrunk by 153% YoY
MED's net income has shrunk by 97% YoY and by 93% QoQ
Medifast's net margin has plunged by 91% YoY and by 88% from the previous quarter
Price vs fundamentals
How does MED's price correlate with its fundamentals
Growth
What is Medifast's growth rate over time
Valuation
What is Medifast stock price valuation
P/E
590
P/B
0.6
P/S
0.3
EV/EBIT
N/A
EV/EBITDA
2.69
EV/Sales
0.1
The EPS has dropped by 97% year-on-year and by 94% since the previous quarter
MED's P/B is 91% below its 5-year quarterly average of 6.9 and 23% below its last 4 quarters average of 0.8
The equity has grown by 3.6% YoY
The P/S is 69% lower than the 5-year quarterly average of 1.0 but 3.3% higher than the last 4 quarters average of 0.3
MED's revenue is down by 36% year-on-year and by 11% since the previous quarter
Efficiency
How efficient is Medifast business performance
The return on sales has dropped by 140% year-on-year
The return on invested capital has dropped by 128% year-on-year
MED's ROE has shrunk by 97% YoY and by 94% QoQ
The ROA has plunged by 96% YoY and by 92% from the previous quarter
Dividends
What is MED's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Medifast financials performed over time
The company's quick ratio has surged by 58% YoY and by 5% QoQ
MED's current ratio is up by 43% year-on-year
Medifast's debt is 94% less than its equity
Medifast's debt to equity has decreased by 33% YoY
Medifast's debt has decreased by 30% YoY and by 6% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.